About Theodore Maidenberg
Form D filings for Time Therapeutics from 2021 to 2024 list Theodore Maidenberg as director.
Theodore Maidenberg first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Theodore Maidenberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Theodore Maidenberg works with at each company, as listed on that company's latest Form D.
Time Therapeutics Inc. · Form D, Jul 2, 2024
MA
Mohammad Saad Alam
CEO and director
SB
Stuart Blitz
Executive officer and director